Installation Capable Of Producing 40 Million Doses Of Covid 19 Vaccine Opens Annually In Saskatoon

SASKATOON – A new center that can develop up to 40 million doses of COVID-19 vaccine a year has opened in Saskatoon. The University of Saskatchewan Vaccine and Infectious Diseases Agency has completed construction of the Level 3 Restriction Facility. This means that it can make vaccines for both humans and animals for dangerous viruses. Officials say the facility will allow Canada to make its own vaccines and be less dependent on other countries. The university says the Level 3 categorization makes it the first facility of its kind in Canada. Achieving this level brings the lab one step closer to establishing the facility as a pandemic research center in Canada. This Canadian Press report was first published on June 28, 2022. The Canadian Press

title: “Installation Capable Of Producing 40 Million Doses Of Covid 19 Vaccine Opens Annually In Saskatoon " ShowToc: true date: “2022-12-12” author: “Allen Kositzke”

The University of Saskatchewan Vaccine and Infectious Diseases Agency has completed construction of the Level 3 Restriction Facility. This means that it can make vaccines for both humans and animals for dangerous viruses. Officials say the facility will allow Canada to make its own vaccines and be less dependent on other countries. The university says the Level 3 categorization makes it the first facility of its kind in Canada. Achieving this level brings the lab one step closer to establishing the facility as a pandemic research center in Canada. Sign up for Coronavirus newsletter to read the basics of the day about coronavirus, features and explanations written by Globe reporters and editors.

title: “Installation Capable Of Producing 40 Million Doses Of Covid 19 Vaccine Opens Annually In Saskatoon " ShowToc: true date: “2022-11-15” author: “Richard Norman”

SASKATOON – A new center that can develop up to 40 million doses of COVID-19 vaccine a year has opened in Saskatoon. The University of Saskatchewan Vaccine and Infectious Diseases Agency has completed construction of the Level 3 Restriction Facility. This means that it can make vaccines for both humans and animals for dangerous viruses. Officials say the facility will allow Canada to make its own vaccines and be less dependent on other countries. The university says the Level 3 categorization makes it the first facility of its kind in Canada. Achieving this level brings the lab one step closer to establishing the facility as a pandemic research center in Canada. This Canadian Press report was first published on June 28, 2022. The Canadian Press